New England PharmAssociates

Excellence in life sciences asset development


NEPAblog is where our Principals, Associates and Guests share their insights and look forward to thoughtful exchanges with readers.

  • To SBIR...Or Not To SBIR

    Now that the government is back up and running, it is time for aspiring grant recipients to get serious about the December 5th SBIR/STTR application deadline. SBIR funding can be very helpful for enabling a company to launch or to grow. However, committing to the SBIR application route means a considerable amount of work over much time – might as well get started.

    » More
  • The Myriad Ruling - An Important Message to Biotech CEOs

    The US Supreme Court has issued a long-awaited decision in Myriad Genetics, which sent shockwaves through the very foundation of the biotech industry. The decision invalidated one of Myriad’s patents on mutated BRCA-gene sequences associated with increased risk of breast cancer.

    » More
  • Got Lab? Time to Check Out a Biotech Incubator

    A critical advantage that business incubators offer is the availability of fully functional infrastructure – enabling entrepreneurs to focus on their fledgling businesses without having to worry about time-consuming operational bits like setting up permits, licenses, internet access, waste disposal, meeting space, security, vendor negotiations etc.

    » More
  • Crowdfunding for Life Sciences - Risky Business?

    The JOBS Act (Jumpstart Our Business Startups) may transform the way that startups in the Life Sciences are funded (at least initially) as crowdfunding fills the gap that was held by more traditional Angel and Venture investors.

    » More
  • Virtually Real Biotech

    In my last post, I mentioned pros and cons of both virtual and traditional biotech business models, mostly using the words of panelists in the 2012 MassBio Annual Meeting panel on this subject. I also suggested that virtual biotech is quite real – outsourcing life sciences R&D has become increasingly common, with a variety of vendor options.

    » More
  • Virtual Companies vs Bricks and Mortar at MassBio

    The MassBio Annual Meeting concluded yesterday after two days of presentations, panel discussions and awards. Of course, the backbone of the event was the action packed agenda featuring high impact speakers ranging from CEO’s and Senior executives of world class corporations to a high school Senior from Norton High school who (speaking to a crowd of ~500 people!!) demonstrated quite convincingly why her school won the MassBioEd Innovative School of the Year Award.

    » More
  • Accelerating Drug Development…With Contract R&D

    I am getting set to moderate a panel discussion at MassBio’s upcoming symposium: “Accelerating Drug Development” – it will be well worth a day trip to Bentley University, in nearby Waltham.

    » More
  • Pitching Perfectly at InnoVentures U

    Yesterday’s class was a milestone of sorts for the education arm of North Shore InnoVentures (NSIV). NSIV, for those who are unfamiliar, is a start-up incubator located in Massachusetts on the…um…North Shore.

    » More
  • Northeastern is Minding its Biotech Business

    I’ve always enjoyed teaching – and have gained great satisfaction from having the opportunity to learn something new while sharing knowledge with someone else. For most of my professional life, this has taken the form of tutoring students, coaching employees and mentoring new entrepreneurs. So when I stumbled upon an opportunity to teach a course at Northeastern University, I jumped in with both feet.

    » More
  • Does Your Life Sciences Start-up Need an Advisory Board (hint…YES!)?

    Just yesterday, 16 November, the North Shore InnoVentures educational arm – InnoVentures U – featured David H. Gibbs, PC, Partner at Bowdy & Dewitch, presenting: Using Advisory Boards to Enhance Company Performance. While acknowledging that a Board of Directors (BOD), with fiduciary duties and management oversight responsibility, is an important organizational tool, this session assumed the presence of a BOD and focused on the importance of Advisory Boards.

    » More
Page 1 of 1